Sign Up for Email Alerts Visit us on Twitter Visit us on Facebook Visit us on YouTube Subscribe to RSS Feeds


 

Contact Us

202-789-2300
info@allhealth.org

1444 Eye Street, NW, Ste. 910
Washington, DC 20005-6573


Sen. Roy Blunt
Honorary Co-Chairman

Sen. Ben Cardin
Honorary Co-Chairman


Dr. Bob Graham
Chairman

In The Spotlight

Biosimilars in the United States: Next Steps

Briefing Monday, June 20, 2016

With biosimilar biological products moving from the lab to the marketplace, key policy and regulatory questions are being actively debated, with important implications for industry, patients, and the health care system. This discussion will provide background on current policy and regulatory issues surrounding biosimilars, and it will consider implications for the future, answering critical questions such as: What does the future of the biosimilars market hold for patients? What information do patients and their physicians need about these medicines? What role will payers play in educating health care professionals and patients? Read More

Recent Briefings

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) repealed the Sustainable Growth Rate formula (SGR) and set out a blueprint for reforming physician payment under Medicare with an eye towards better aligning Medicare payments with the cost and quality of patient care. On April 27, 2016, the Department of Health and Human Services (HHS) issued a proposed rule to implement the law. While the proposed rule provides more clarity on how to move the health care system from volume to value, questions about implementing the law remain among policymakers, providers, and patients. Read More

Recent pharmaceutical innovations offer unprecedented possibilities for curing, treating, or preventing a range of diseases. However, patients, providers and payers alike have raised concerns about the affordability and sustainability of these drugs. As a response to price increases of both single-source and generic drugs, some stakeholders are calling for a move towards basing payments on value, and some payers and pharmaceutical manufacturers are exploring ways to base payments on outcomes. However, many challenges remain.  Read More

Medicare is testing new ways to pay for medical services, emphasizing value rather than volume, and evidence is beginning to build about successes and challenges. This briefing will examine what we know so far about the basic models, savings, quality, the impact on patients and the prospects for replication. Read More


MACRA: New Directions for Medicare Physician Payment


Get Alliance Updates

Sign Up for Email Alerts Visit us on Twitter Visit us on Facebook Visit us on YouTube Subscribe to RSS Feeds


Health Care Consolidation: What You Need to Know


A recent whirlwind of mergers and acquisitions has thrown health care industry consolidation into the spotlight. In 2014 alone, there were 1,299 mergers and acquisitions in the health care sector at a value of $387 billion, a new record. In this roundtable for reporters, featuring a top FTC official and two experts, panelists discussed the drivers behind this recent trend; the scope and extent of consolidation among doctors, hospitals and insurers; implications for consumers and other stakeholders; and the roles of the Department of Justice (DOJ) and the Federal Trade Commission (FTC).

Click here for video
Click here for transcript

Read More

New Toolkit on Health Care Consolidation


There were 1,299 mergers and acquisitions in the health care sector in 2014 at a value of $387 billion, both record highs. A new Alliance for Health Reform toolkit, “Health Care Consolidation,” looks at the drivers behind this trend, as well as implications for key players in the health care system and regulatory issues surrounding the issue.  Critics argue that consolidation could have a harmful impact on consumers, including higher costs, while others say some amount of activity is necessary to reshape the health care industry following changes implemented by the Affordable Care Act.

Read More

Copyright 1997-2016 Alliance for Health Reform
1444 Eye Street, NW, Suite 910 Washington, DC 20005-6573      202-789-2300      202-789-2233 fax      info@allhealth.org      Sitemap